Table 3.
Summary of clinical significance thresholds for critical and important outcome measures.
Outcome Tool | Clinical Significance Threshold* | Desired Change |
---|---|---|
Accident risk | 10% | Decrease |
Cataplexy | — | — |
Diary-based daily/weekly episode frequency | 25% | Decrease |
Severity | 25% | Decrease |
Cognitive performance | — | — |
Psychomotor vigilance test—reciprocal reaction time | 10% | Increase |
Difficulty waking in the morning | — | — |
Varies | 0.5 standardized mean difference | Decrease |
Disease severity | — | — |
CGI | 1-point OR | Decrease |
33% of patients reporting change | Improvement | |
PGI | 1-point OR | Decrease |
33% of patients reporting change | Improvement | |
Frequency and duration of symptoms | 10% | Decrease |
Number of d incapacitated | 10% | Decrease |
Other quantitative tools | 10% | Improvement |
Other qualitative tools | 33% of patients reporting change | Improvement |
Excessive daytime sleepiness | — | — |
ESS | 2 points | Decrease |
ESS-CHAD | 2 points | Decrease |
MWT | 2 min | Increase |
MSLT | 1 min | Increase |
SSS | 1 point | Decrease |
Fatigue | — | — |
FSS (global change) | 0.5 points | Decrease |
SF-36 energy/vitality subscale | 3 points | Increase |
BFI | 0.3 points | Increase |
FIS | 4.8 points | Increase |
MAF (global change) | 5.0 points | Increase |
Mood | — | — |
BDI | 5 points | Decrease |
CDI | 6 points | Decrease |
PHQ-2 | 1 point | Decrease |
PHQ-9 | 2 points | Decrease |
Quality of life | — | — |
FOSQ | 1 point | Increase |
PedsQL | 1 point | Increase |
SF-36 | — | — |
(Physical Component Summary) | 3 points | Increase |
(Mental Component Summary) | 3 points | Increase |
SF-12 | 4 points | Increase |
Sleep inertia | — | — |
Varies | 0.5 standardized mean difference | Decrease |
Sleep quality | — | — |
PSQI | 3 points | Decrease |
PSG/actigraphy-based sleep efficiency (%) | 10% | Increase |
Work/school performance/attendance | — | — |
Varies | 0.5 standardized mean difference | Increase |
*The clinical significance threshold applies to the comparison of posttreatment effects between intervention and placebo as well as a pre-/post treatment difference. BDI = Beck’s Depression Inventory, BFI = Brief Fatigue Inventory, CDI = Children’s Depression Inventory, CGI = Clinical Global Impression of change, ESS = Epworth Sleepiness Scale; ESS-CHAD = Epworth Sleepiness Scale for Children and Adolescents, FIS = Fatigue Impact Scale, FSS = Fatigue Severity Scale, FOSQ = Functional Outcomes of Sleep Questionnaire, MAF = Multidimensional Assessment of Fatigue, MSLT = Multiple Sleep Latency Test, MWT = Maintenance of Wakefulness Test, PGI = Patient Global Impression of change, PedsQL = Pediatric Quality of Life Inventory, PHQ-2 = Patient Health Questionnaire-2, PHQ-9 = Patient Health Questionnaire-9, PSG = polysomnography, PSQI- Pittsburgh Sleep Quality Index, SF-12 = 12-Item Short-Form Health Survey, SF-36 = 36-Item Short-Form Health Survey, SSS = Stanford Sleepiness Scale.